Open access peer-reviewed chapter

Some Igbo Indigenous Plants with Anti-COVID-19 Properties

Written By

Obeta M. Uchejeso, Ikeagwulonu R. Chinaza, Ohanube A.K. Goodluck and Jwanse I. Rinpan

Submitted: 18 August 2020 Reviewed: 29 September 2020 Published: 09 November 2020

DOI: 10.5772/intechopen.94244

From the Edited Volume

Alternative Medicine

Edited by Muhammad Akram

Chapter metrics overview

1,004 Chapter Downloads

View Full Metrics


Coronavirus (COVID-19) has shaken the world not minding the strength of the global health system leading to over 824, 000 deaths amidst the search of a cure and total prevention. The Igbo states in Nigeria has the average prevalence of 711 cases of COVID-19 with the highest 1096 (Enugu) and least 207 (Anambra) as at 26th August, 2020. This chapter studied some Igbo indigenous plants in use since the outbreak and presents Bitter kola, Garlic, Giloy, Ginger, Lime, and Turmeric which are having anti-COVID-19 properties. The authors suggest that these plants have the properties that alter the PH on the interface between the virus spike proteins and the human respiratory surfaces causing a brake on the interaction with human ACE-2 and where interaction has taken place, the replication and translation stages are disrupted. The plants thus are potential modifiers of this milieu and inhibitor of the main protease and endoribonuclease via epigenetics and homeostasis. These plants consumption should be encouraged as prophylactic or curative measures pending the discovery of a definitive cure. The chapter recommends that the search for COVID-19 cure should not be limited to conventional medicines, rather should be extended to some indigenous plants in Igbo land.


  • Igbo plants
  • anti-COVID-19
  • bitter kola
  • garlic
  • giloy
  • ginger
  • lime
  • turmeric

1. Introduction

COVID-19 pandemic is a global threat without any confirmed treatment regimen. The global community is on the trail to get preventive and treatment measures. The pandemic burden has increased the effort of traditional/herbal medicine practitioners across the globe and, Nigeria in particular towards arriving at a cure for the novel virus. Coronavirus (SARS-COV-2), a zoonotic disease and the seventh member of coronaviruses was named COVID-19 and officially declared a pandemic on 11th February, 2020 and 11th March, 2020 respectively [1, 2]. There is no doubt that COVID-19 has posed a challenge to the best healthcare systems around the world; giving a leeway to herbal/plant experts to demonstrate their capacity.

On 26th August 2020, using Corona Scanner Realtime coronavirus statistics App (Free online dashboard solution), the Coronavirus has infected 215 countries of the world. Global Infections are 24,092,885 with 824,194 deaths showing 3.42% death rate and 69.04% survival rate (16,634,272 recovery) with daily infection rate at 223,070 persons. Nigeria is ranking 50 on the global list of infections with 52,800 reported cases, 1007 deaths showing a 1.91% death rate, and 75.69% survival rate (39,964 recoveries) as at 1.10 pm with a daily infection rate of 460 persons.

The COVID-19 pandemic is currently recording a higher number of infections on a daily bases because many Nigerian researchers had advocated stepping up of medical laboratory testing. The increased prevalence of COVID-19 is noted because of increased testing capabilities in various countries and, Nigeria, in particular [3, 4]. Already, the community transmission of the virus has increased while spread could be attributed to the zoonotic nature [5, 6] of the COVID-19. All approaches be it, surveillance, molecular testing, immunomodulation, conventional, or phytomedicine towards stopping the COVID-19 pandemic that needs to be adopted [7, 8].

In Africa, the use of herbs and concoctions in the management of various ailments has been recorded [9], and COVID-19 cannot be exempted. The index case as announced in Nigeria by FMOH [6, 10] left many herbal medicine practitioners to go back to their various products that could be used to contain the pandemic. The first line of herbs in consideration are edible and nutritious vegetables that could be readily approved by the scientific world have been consumed without toxic effects or have been scientifically approved in the past. This is where Bitter kola (Garcinia kola) Garlic (Allium sativum), Giloy (Tinospora cordifolia), Ginger (Zingiber officinale), lime (Citrus limonum), and Turmeric (Curcuma longa) belong and can be easily assessed and verified.


2. Igbo land in the time of COVID-19

Igbo land “Ala Igbo” is the South Eastern zone of Nigeria located at 1000 m (3,300 ft) above sea level and covers the area 41,440 km2.

South-Eastern Nigeria (Igbo land) is part of the old eastern region that was part of Biafra. This geopolitical region is made up of five (5) states- Abia, Anambra, Ebonyi, Enugu, and the Imo States, as highlighted in Figure 1.

Figure 1.

Nigerian states COVID-19 status as at 26th august 2020 by 11.59 pm as accessed from NCDC [11].

The language spoken in southeastern Nigeria is the Igbo language.

As of 26th August 2020 based on NCDC COVID-19 Situation Report (situation report 180), shows that Igbo land had 3553 cases out of 53,021 cases recorded in Nigeria with lowest case fatality of 8.32% (84 out of 1010 death cases in Nigeria) as derived from Figure 1 [11].

Though there may be other factors that may be responsible for the fatality cases, the authors observed that the indigenous people of Igbo land both home and in diaspora made use of some of their indigenous plants during the COVID-19 not minding their places of abode.


3. Some Igbo indigenous plants

Replace Conventional medicine utilizes active compounds mostly isolated from some medicinal plants to the extent that about 80% of the active ingredients indicate a positive correlation between their modern therapeutic uses and herbal or traditional use depending on where the plants are found [12]. Igbo indigenous plants and herbs have been used for treating and preventing several diseases, including respiratory viral infections in the past. The current novel virus also poses a challenge to which conventional or herbal medicine would be useful and no wonder some Igbo indigenous plants and herbs are listed for consideration in a bid to discover the COVID-19 management drugs and cure. Such plants understudy in this chapter is bitter kola, garlic, giloy, ginger, lime, and turmeric.

3.1 Bitter kola

Plant name: Bitter kola.

Pictorial exposition (Figure 2):

Figure 2.

Bitter kola fruits on the plant and bitter kola seeds.

Botanical name: Bitter kola – Garcinia kola.

Indigenous (local) name: Aku ilu.

Taxonomical classification:

Kingdom: Plantae.

Division: Magnoliophyta.

Class: Magnoliopsida.

Order: Theales.

Family: Clusiaceae.

Genus: Garcinia.

Species: kola.

Part of the plant in Use: Seeds.

Phytochemical components:

Several studies have been carried out on the phytochemical components of Garcinia kola. Such studies have shown that Garcinia kola contains alkaloids, saponins, tannins, flavonoids, glycosides, sterols, and phenols. The major constituents of the plant are kolaviron, garcinia biflavonoid (GB-1a-glucoside, GB-1a, GB-1, GB-2), kolaflavonone, benzophenone, xanthone, coumarin, apigenin, quercetin, and garcinoic acid [13, 14, 15, 16, 17].

Hexadecanoic acid, 9-octadecanoic acid, methyl ester, linoleic acid, heptadecane-(8)-carbonic acid, formaldehyde, N, N-Diethyl, n-tetradecanoic acid amide; 3,4,8-trimethyl-2-nonenal were gotten from the seed of Garcinia kola. Carbohydrates were separated from the seed. The mineral composition of G. kola seeds extracts was also reported [18]. The seed contains an enormous amount of potassium and phosphorus. Other constituents include ash, crude protein, crude fiber, crude lipid, water-soluble oxalate, terpenoids, and fat [19].

Gas–liquid chromatography and High-Performance Liquid Chromatography was used to study these phytochemical contents of Garcinia kola. The seed oil was found to contain fatty acid and amino acid derivatives, namely meristic, pentadecanoic, margaric, trans-palmitoleic, cis-vaccenic, cis-oleic, cis-linoleic, α-linolenic, threonine, tyrosine, methionine, serine, histidine, and alanine [20].

Based on dietary properties, the following have been found: moisture (7.2%–92.7%); crude protein (0.58%–7.8%); ash (0.33%–5.9%); crude fiber (1.23%–20.51%); crude fat (0.19%–14.5%); and NFE (10.85%–91.35%). The dominant fatty acids in the seed are oleic (38 mg/kg), linoleic (36 mg/kg), and palmitic acid (32 mg/kg). The prevalent essential amino acids are lysine (2.4 g/kg), leucine (1.9 g/kg), and valine (1.7 g/kg), and nonessential amino acids are glutamic acid (6.8 g/kg) and arginine (5.5 g/kg). The bitter kola seeds are low in anti-nutrients such as phytate or oxalate. However, high amounts of vitamin C have been recorded up to 23.1 mg/100 g. Potassium (722 mg/kg) and phosphorus (3.3–720 mg/kg) were recorded in bitter kola as the most abundant minerals in bitter kola seeds [21].

Health benefits:

The medicinal importance of bitter kola is based mainly on the photochemical components of the plants. Some of these components isolated include oleoresin, tannin, saponins, and alkaloids. Other components isolated from bitter kola seeds are bioflavonoids such as kola flavanone, and hydroxy flavonoids. Bitter kola is highly valued in African ethnic medicine because of its varied and numerous social and medicinal uses, thus making it an essential ingredient in folk medicine. Herbal Medicine has been advocated as a major contributor to the cure of many ailments [922] and Bitter kola is believed to be an important source of flavonoids and chemical substances with potential therapeutic benefits especially in the treatment of diabetes [23].

Omeh et al. posit that bitter kola is cardioprotective because of the lipid reduction ability [24].

The bitter kola is commonly chewed by both rural and urban dwellers for treating gastric problems or for their typical astringent taste. The bioflavonoid kolaviron complex content of bitter kola is anti-inflammatory, neuroprotective, and antimicrobial. Kolaviron possesses anti-malarial and wound healing effects. Kolaviron is useful in the treatment of benign prostatic hyperplasia, multiple sclerosis, and AIDS. It has shown the capacity to stop Ebola virus growth in medical laboratory trials [21].

Kolaviron possesses antinociceptive (sedative) and anti-inflammatory activities, both centrally and peripherally, which justifies its folkloric use to relieve pain and inflammation. Moreover, Abarikwu [25] revealed that kolaviron could block signaling pathways implicated in lipopolysaccharide-induced inflammatory genes and equally prevent oxidative stress. It also helps in demyelination and neurotoxicity. It aids in the treatment of multiple sclerosis that can be clinically viable against ischemia/reperfusion injuries.

Bitter kola has hepatoprotective properties, promotes survival of hepatocytes, and prevents liver injuries and intoxication. In rat models, bitter kola is anti-diabetic and protecting against hyperglycemia-induced apoptosis, attenuate the level of lipid peroxidation. Bitter kola has anti-malarial activities.

Nworu et al. [26] discovered its immunomodulatory and immuno-restorative effects, making it useful in fighting immune-destructive diseases such as acquired immunodeficiency syndrome (AIDS) and other viruses which may include COVID-19.

Bitter kola wether as alcoholic or aqueous extracts has antimicrobial properties against many multidrug-resistant bacteria (gram-positive and gram-negative) and fungi [21].

Possible Toxicology:

There is speculation that only high doses of Kolavirons (400 mg/kg) can cause liver damage but its ability to inhibit cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS) expression through downregulation of nuclear factor kappa B (NF-κB) and activator protein-1 (AP-1) DNA binding activities shows the hepatoprotective properties of Kolaviron content of bitter kola [21].

Anti-COVID-19 Properties:

Guttiferones are polyisoprenylated benzophenone derivatives of bitter kola that can inhibit the cytopathic effects of the virus responsible for HIV infection [27].

Garcinol has the same or even very similar structure to that of Guttiferone F that has similar properties. However, relatively few studies have been reported describing the design and performance of bitter kola constituents and drug delivery systems on its proposed antiviral properties. [28]. Reports of use during COVID-19 [29] are helpful in bitter kola effects against the pandemic.

3.2 Garlic

Plant name: Garlic- Allium sativum.

Pictorial exposition (Figure 3):

Figure 3.

Garlic plants and the bulbs.

Botanical name: Allium sativum.

Indigenous (local) name: Yabasi Hausa.

Taxonomical classification:

Kingdom: Plantae.

Division: Magnoliophyta.

Class: Monocotyledonae.

Order: Liliales.

Family: Liliaceae.

Genus: Allium.

Species: Sativium.

Part of the plant in Use: Bulb.

Phytochemical components:

Garlic contains carbohydrates, glycosides, and proteins in high concentrations; alkaloids, saponins, reducing sugars, oils, and steroids in medium concentrations, while flavonoids and acidic compounds were present in low amounts [30].

Phytochemicals screening revealed the results that alkaloids, reducing sugar, flavonoids, glycosides, cardiac glycosides, tannin and phenolic compounds, saponins, amino acid & triterpenoids in aqueous extract but methanolic extract shows the absence of reducing sugar [31].

Health benefits:

Garlic is useful in chronic cough, arthritis, and constipation. Garlic has also been mentioned to protect from epidemic diseases, and no wonder it is always reckoned during COVID-19. Many studies revealed that garlic has antioxidant, anti-inflammatory, immune-modulating, antibiotic, bacteriostatic, antifungal, antiviral, antihelminthic, antithrombic, hypotensive, hypoglycemic, and hypocholesterolemic properties [32].

Garlic has shown a virucidal effect on human rhinovirus-2, parainfluenza virus-3, HSV-1, HSV- 2, and vesicular stomatitis virus during in vitro study by Weber et al. [33].

Kang et al. [34] explored the antioxidant and reactive oxygen species scavenging property of saponins produced by garlic while Naji et al. [35] demonstrated the hepatoprotective and antioxidant property of single clove garlic in rabbits’ models.

Garlic used for management of abdominal discomfort, diarrhea, otitis media, and respiratory tract infections in the eastern part of Nigeria [36] and treatment of common colds, hay fever, and asthma in Europe and India [37].

The garlic has immunomodulation, anti-inflammatory, and antioxidant with cardioprotective, and pulmonary protective properties [32].

Possible Toxicology:

Fowotade et al., [37] reported a dose-dependent increase in levels of liver enzymes AST, ALT, and ALP) as well as an increase in serum creatinine levels and dose-dependent histologic alterations in hepatic, renal, and cardiac tissues in rat models indicating toxicity at higher dozes to the liver, heart, and kidney.

Anti-COVID-19 Properties:

Garlic modulates cytokine expression in lipopolysaccharide activates human blood and inhibits NF-κB from which makes it immune-modulatory. It activates macrophages and promotes immunoglobulins. Garlic extract reduces the migration of polymorphonuclear cells through endothelial cell layers. Garlic inhibits the production of nitric oxide and prostaglandin-E2, suppresses the inducible form of nitric oxide synthase and COX-2 expression, and decreases the production of inflammatory cytokines like TNF-α, interleukin six, and interferon γ. It improves lung function in smokers and reduces tracheal exudates in horses. It is useful in inflammatory and asthma-like conditions of the lungs [37].

The exploits in pharmacologic actions in handling respiratory diseases and other viruses are possible in handling COVID-19.

3.3 Giloy

Plant name: Giloy - Tinospora cordifolia.

Pictorial exposition (Figure 4):

Figure 4.

Giloy leaves on the plant and Giloy stems.

Botanical name: Tinospora cordifolia.

Indigenous (local) name: Udo akpu enyi.

Taxonomical classification:

Kingdom: Plantae.

Division: Magnoliophyta.

Class: Magnoliopsida,

Order: Ranunculaceae.

Family: Menispermeaceae.

Genus: Tinospora.

Species: cordifolia.

Part of the plant in Use: Root, Stem, Back, Leaves, and Fruits. This implies that all the parts of the plant are useful as an herbal remedy of one disease or the other depending on the preparation.

Phytochemical components:

Giloy contains polysaccharides, phenolics, diterpenoids, steroids, and sesquiterpenoids [38]. Singh and Chaudhuri [39] reported that giloy has the following components:

Alkaloids – Giloy has 13 alkaloids of isoquinoline and aporphine skeletons, amine, and amide with main alkaloids that are protoberberine alkaloids berberine, corydine, magnoflorine, and palmatine.

Terpenoids – Giloy has 32 diterpenoids and their glycosides of clerodane and norclerodane skeleton, 5 sesquiterpenoids, 1 monoterpenoids, and 1 triterpenoid cycloeuphordenol. There is also a bicyclic diterpenoid (C21H24O7) from the whole plant identified as tinosporin.

Phenolics – Giloy has 4 phenylpropanoids, 3 lignans, 2 flavonoids, and 2 benzenoid derivatives.

Steroids – Giloy has 4 steroids along with δ-sitosterol and 2,3,14,20,22,25-hexahydroxyl-5-cholest-7-en-6-one.

Essential oil and aliphatic compounds – Giloy hydro distilled essential oil of fresh leaves showed the presence of alcohols (32.1%), phenols (16.6%), aldehydes (16.2%), fatty acids (15.7%), alkanes (8.3%), esters (3.2%), and terpenes (1.2%), along with hydroquinone (16.6%), 2-hexenal (14.2%), palmitic acid (14.1%) and phytol (11.4%). Also, hexane extract of giloy stems revealed methyl-9,12-octadecadienoate (23.2%), methyl 9-octadecenoate (19.7%), methyl hexadecanoate (16.3%), and methyl octadecanoic (5.5%) but Heptacosanol, octacosanol, nonacosan-15-one and cyclohexyl-11-heneicosanone were seen in the whole plant extract.

Polysaccharide – Giloy stems polysaccharide shows glucose 98.0%, arabinose 0.5%, galactose 0.3%, mannose 0.2%, rhamnose 0.2%, and xylose 0.8% units.

Others – Other compounds seen in giloy are giloinsterol, a bitter glucoside giloin, a non-glucoside bitter substance giloinin, gilo-sterol, tinosporan acetate, tinosporic acid, tinosporal acetate, tinosporone, and tinosporal. Bitter compounds found in giloy are tinosporide and cordifolide. There are also 3 furanolactone diterpenoids -C20H20O6, C20H22O8 and C26H34O11.

The giloy leaves are also rich in protein, calcium and phosphorus [40].

Health benefits:

Chemical components and products from giloy have been found to have free radical scavenging properties and decrease the activities of superoxide dismutase and glutathione peroxidase in rats [41].

Anti-inflammatory properties like that of indomethacin and nonsteroidal drugs have been found in giloy. Giloy reduces histamine-induced bronchospasm in animals. 1, 4-alpha-D-glucan derived from giloy activates macrophages, NFκB translocation, and cytokine production, and hence activates the immune system. Giloy favors HIV positive patients. Giloy helps young chicks under infectious bursal disease during conventional antiviral treatment. Vedavanthy et al. [42] demonstrated antipyretic and Gupta et al. [43] observed its antimicrobial effects. Researcher [39] analyzed the parts thus:

Leaves: Powdered leaves preparations help in treating gout, ulcers, jaundice, fever, and wounds, and to control blood glucose.

Stem: The mixture of stem extract alone or with honey is useful in treating jaundice, skin diseases, and fever. The stem starch (Sativa) can also be used as a tonic and as an antidote to snakebite and scorpion sting.

Bark: In India, the root and stem bark of the plant is used along with milk to treat cancer.

Fruits: Are used in the treatment of jaundice and rheumatism.

Roots: Roots are used as an emetic for visceral obstructions, leprosy, diarrhea, and dysentery.

Possible Toxicology:

Giloy has been described as a safe drug to use. There is no available report on its toxicity on humans though regular use of giloy in high doses can cause constipation [39].

Anti-COVID-19 Properties:

Giloy is the source of various types of bioactive compounds, including alkaloids, steroids, glycosides, and aliphatics. Giloy may have inhibitor potential as a drug for SARS-CoV-2 otherwise called COVID-19 with phytochemicals such as berberine, ß-sitosterol, octacosanol, tetrahydropalmatine, and choline with 3CL pro targets I, II of protease enzymes.

3.4 Ginger

Plant name: Ginger - Zingiber officinale.

Pictorial exposition (Figure 5):

Figure 5.

Uprooted ginger plants and rhizomes.

Botanical name: Zingiber officinale.

Indigenous (local) name: Jinja.

Taxonomical classification.

Kingdom: Plantae.

Division: Angiosperms.

Class: Monocots.

Order: Zingiberales.

Family: Zingiberaceae.

Genus: Zingiber.

Species: officinale.

Part of plant in Use: Rhizomes.

Phytochemical components:

The phytochemical components reveal: citronellal, linalool, borneol, 10-dehydrogingerdione, 6- et 4,6, 8 ou 10-gingerdione, limonene; [6]-methyl gingediol, le [4]-gingediacetate, le [6]- gingediacetate, and le [6]-methyl-gingediacetate.

Constituents of essential oils are: curcumene, farrnesene, gingerols, zingiberene, zingerone, car-3-ene, α-terpinene, shogaols, paradols, αterpineol, neurol, 1, 8-cineole, neral, geranial, geraniol et geranyl acetate, isovaleraldehyde, nonanol, ethylpinene, α-Pinene, α-sesquiphellandrene, β-bisabolene myrecene, β-pinene, β sequithujene, sesquiphellandrene, camphene, sabinene, cis-sequisabinene hydrate, zingiberol, gingerone, and citral (geranial et neral).

Macronutrients found are carbohydrates, fiber, and proteins (with amino acids such as cystine, phenylalanine, histidine, isoleucine, methionine, tyrosine, threonine, leucine, lysine, tryptophan, valine), lipids (including omega 3, 6 and 9 fatty acids).

Micronutrients found are sodium, magnesium, phosphorus, potassium, calcium, magnesium, manganese, phosphorus, potassium, sodium, selenium, iron, copper, zinc, selenium, iodine, vitamins A (thiamine), B1 (thiamine), B2 (Riboflavin), B3 or PP or niacin, B5, B6 (pyridoxine), B9 (folic acid), C, D, E, K1, and K2.

Other Compounds present are: Flavonoids (Flavan-3-ol, flavone, flavonol, flavanone, tannins, quercetin, rutin, fisetin, morine, gallic acid, ferulic acid, vanillic acid, hexahydrocurcumin and desmethyl-hexahydro curcumin, 3S,5S)-3,5-diacetoxy-1,7-bis(4-hydroxy-3-methoxyphenyl), allicin, alliin, ajoene, galanolactone, gingerenones, and gingediones [44].

Health benefits:

Considering many bioactive ingredients like gingerol, zingiberine, shogaol, gingerdione, hexahydrocurcumin, paradol and gingerenone A, ginger has antioxidants that help reduce oxidative stress and inhibit superoxide production.

Dried ginger possesses potent anti-inflammatory and analgesic activities.

Ginger has a better effect against swine flu (H1N1), and human respiratory syncytial virus in human respiratory tract cell lines.

There are antiretroviral sesquiterpenes in ginger.

Ginger provides a bronchodilatory effect, prevents severe damage to the lungs due to inflammation, and ameliorates allergic asthma.

Gingerol can be used to prevent and treat cancer and chronic inflammatory diseases. It has an antiparasitic effect, especially against Ichthyophthirius multifiliis (ciliate parasite of freshwater fish). The bioactive bitter and pungent component of ginger and its derivatives, reduced heavy menstrual bleeding in women of reproductive age; and protected rat fetuses against Gabapentin-induced hepatotoxicity. Ginger improved concentration of blood lipid and reduced body overweight, obese, and have an anti-diabetic effect [45].

Possible Toxicology:

In rats, 2500 mg/kg gave a toxic effect leading to severe hypotension and bradycardia with the induction of prenecrotic changes in cardiac tissues, but 50 mg/kg given for 28 days gave bradycardia to the rats with waviness in cardiac muscle fibers [46]. Idang et al. [47] describe the effect of ginger on some organ’s histology and biochemical parameters as reversal when the administration is discontinued in rat models.

Anti-COVID-19 Properties:

The anti-inflammatory, analgesic, and antiviral activities of ginger provide the positive property that COVID-19 can be managed by ginger.

3.5 Lime

Plant name: Key Lime - Citrus aurantifolia.

Pictorial exposition (Figure 6):

Figure 6.

Lime fruits on the plant and plucked fruits.

Botanical name: Citrus aurantifolia.

Indigenous (local) name: Oroma nkirisi.

Taxonomical classification:

Kingdom: Plantae.

Division: Streptophyta.

Class: Magnoliopsida.

Order: Sapindales.

Family: Rutaceae.

Genus: Citrus.

Species: aurantifolia.

Part of the plant in Use: Fruits.

Phytochemical components:

The aqueous extracts of lime pulp revealed the presence of carbohydrates, reducing sugars, proteins, alkaloids, tannins, fixed oils, cardiac glycosides, phytosterols, phenols, steroids, and flavonoids [48].

The ethanolic pulp extracts showed only the presence of fixed oils, reducing sugars, cardiac glycosides, steroids, phytosterols, flavonoids, and amino acids.

The aqueous peel extracts showed the presence of carbohydrates, alkaloids, tannins, fixed oils, proteins, cardiac glycosides, steroids, phenols and flavonoids, and amino acids [49].

Health benefits:

It is known that due to the presence of various phytochemicals such as alkaloids, flavonoids, glycosides, saponins, steroids, anthraquinones, phenols, resins, fatty acids, and gums present in the plant extracts are responsible for the antibacterial properties. The total phenolic content values have evidence of antimicrobial activity, just like the presence of steroids, flavonoids, alkaloids, tannic acid, and phenolics against both gram-positive and gram-negative bacteria [50].

Lime is popular as antioxidant activity, immunomodulation, and antibacterial activities [48].

Possible Toxicology:

It may cause burns in the mouth, throat, and stomach. It may not be perfect for chronic ulcer patients. However, it is generally less toxic [51].

Anti-COVID-19 Properties:

There is evidence that suggests that lemon essential oils have shown potent antiviral activity to other coronaviruses, such as SARS-CoV-1, and could also be the same in respect of COVID-19 by inhibition of viral infection and replication [52].

3.6 Turmeric

Plant name: Turmeric - Curcuma longa.

Pictorial exposition (Figure 7):

Figure 7.

Turmeric plants and rhizomes in plate.

Botanical name: Curcuma longa.

Indigenous (local) name: Tumerik.

Taxonomical classification.

Kingdom: Plantae.

Division: Angiosperms.

Class: Monocots.

Order: Zingiberales.

Family: Zingiberaceae.

Genus: Curcuma.

Species: longa.

Part of the plant in Use: Rhizomes.

Phytochemical components:

The components reveal α- and β-turmerones, ar-turmerone, atlantone, cineole, d-phallandrene, α-phellandrene, curlone, zingiberene, ar-curcumene, d-sabinene, borneol, terpinolene, 1, 8-cineole, undecanol, and p-cymene [53].

Micronutrients contents are Calcium, Phosphorus, Zinc, Magnesium, Manganese, Copper, Iron, Potassium, Vitamins A, B1 (Thiamine), B2 (Riboflavin), B3 (Niacin), B5, B6, B9, Folate, C (Ascorbic Acid), E, K,

Macronutrients found are: carbohydrates, fiber, lipids (omega 3, omega 6, and omega 9), and proteins.

Other Compounds present includes alkaloids, anthraquinones, curcumin, cyclo-curcumin, cardiac glycosides, demethoxycurcumin, bis-demethoxycurcumin, tannins, terpenes, steroids, saponins, anthocyans, leucoanthocyans, saponins, quinones, and flavonoids [54].

Health benefits:

Turmeric has tremendous medicinal benefits ranging from been used as phlegmagogue, anti-inflammatory, analgesic, antipyretic, blood purifier, to healing properties.

Turmeric is antioxidant, immunomodulating, anti-inflammatory, antimicrobial, and has anticancer activities [55].

The important ingredients of Curcuma longa are curcumin, dihydro curcumin, and hexahydrocurcumin. Some volatile compounds like cinol, α-phellandrene, borneol, zingiberine, and different sesquiterpenes have been found in turmeric. Curcumin has been observed to be extremely effective in acute respiratory distress syndrome, COPD’s, acute lung injury, and pulmonary fibrosis.

Turmeric suppresses NF-α and inhibits NF-κB, in this way acts as a potent anti-inflammatory agent. Curcuma extract acts against various pathogenic bacteria, including Streptococcus, Staphylococcus, Klebsiella pneumonia, Helicobacter pylori, Bacillus subtilis, and Vibrio cholera [55].

The revolutionary potential of turmeric is against viruses like H1N1, H6N1, respiratory syncytial virus, herpes simplex virus, parainfluenza virus type-3, coxsackievirus B3, Japanese encephalitis, hepatitis B virus, hepatitis C virus, human papillomavirus-16, and − 18. It has also been found to inhibit HIV-1 long terminal repeat directed gene expression [55].

Possible Toxicology:

Balaji and Chempakam [56] posit that curcumin and its derivatives may cause dose-dependent hepatotoxicity. They equally put that, in contrast to curcumin, other compounds in turmeric which are non-mutagenic, non-carcinogenic, non-hepatotoxic, and do not have any side-effects.

National Toxicology Program (USA) the toxic and carcinogenic properties of an organic extract of turmeric, called turmeric oleoresin from animal models after a very long time feeding. For example, rats and mice were fed diets containing several concentrations of turmeric oleoresin for three months and two years, and the possible toxic and carcinogenic effects were evaluated. In the 2-year feeding studies, turmeric oleoresin ingestion was associated with increased incidences of ulcers, hyperplasia, and inflammation of the forestomach, cecum, and colon in male rats and of the cecum in female rats. In female mice, the ingestion of diets containing turmeric oleoresin was associated with an increased incidence of thyroid gland follicular cell hyperplasia. These negative effects of curcumin were said to be mediated by several possible mechanisms showing reactive oxygen species (ROS) such as superoxide anion and hydrogen peroxide-based on the facts that:

  1. ROS can induce cell malignant transformation,

  2. Cancer cells commonly have increased levels of ROS,

  3. The malignant phenotype of cancer cells can be reversed by reducing the cellular levels of ROS.

Experimental studies have demonstrated that, although low concentrations of curcumin induce antioxidant effects, while higher concentrations of this compound increase the cellular levels of ROS [57].

However, Aggarwal et al. [55] gave a counter opinion on turmeric when they worked on Curcuminoid-essential oil complex (CEC) and found non-mutagenic effects in all three mutagenic investigations studied. Therefore, following investigations of acute toxicity, repeated dose toxicity, and mutagenicity, CEC was deemed a safe, non-toxic pharmacological formulation.

Anti-COVID-19 Properties:

Soheil et al. [53] compiled other studies on the role of turmeric on some viral infections, thus:

For human immunodeficiency virus (HIV), the presence of curcumin; caused inhibition of HIV-1 LTR-directed gene expression, inhibited Tat-mediated transactivation of HIV-1 LTR and Tat protein acetylation, inhibited HIV-1 integrase while curcumin boron complexes inhibited HIV-1 and HIV-2 proteases though reported no antiviral effect in a clinical trial for HIV.

For Influenza, Curcumin inhibited hemagglutination.

For herpes simplex virus-1 (HSV-1), Curcumin, gallium-curcumin, Cu-curcumin reduced to HSV-1 replication.

For herpes simplex virus-2 (HSV-2), Curcumin gave significant protection in mouse models.

For Coxsackievirus, Curcumin caused replication inhibition through UPS dysregulation.

For hepatitis B virus (HBV), the aqueous extract suppressed HBV replication by increasing the p53 level.

For hepatitis C virus (HCV), Curcumin decreased HCV replication by suppressing the Akt-SREBP-1 pathway.

For human papillomavirus (HPV), Curcumin inhibits expression of viral oncoproteins of E6 and E7 and downregulation effect on the transcription of HPV-18.

For Japanese encephalitis virus (JEV), Curcumin reduced the production of infective viral particles.

For human T-lymphotropic virus-1 or human T-cell leukemia-lymphoma virus-1 (HTLV-1), Curcumin causes downregulation of JunD protein in HTLV-1-infected T-cell lines.

Therefore, if all these viruses can be managed by turmeric, COVID-19 management is possible with this indigenous plant through inhibition, reduced replication, and dysregulation.


4. Possible mechanisms of action of the Igbo indigenous plants against COVID-19

The SARS-CoV-2, otherwise called COVID-19, possess some protein structures by which it enters into the host cells, which is called spike (S) glycoprotein, and forms homotrimers protruding from the viral surfaces. The spike protein interacts strongly with the human ACE2 (angiotensin-converting enzyme 2) receptor [58]. Such interaction is followed by replication through some cyclic processes and translating its genomic RNA (gRNA). There is proteolysis in the presence of viral 3C-like proteinase, with more replication of gRNA. There is viral replication complex formed which consists of RNA dependent RNA polymerase (RdRp), helicase, 30-to-50 exonuclease, endoRNAse, and 20-O-ribose methyltransferase and followed by the assembly of viral components [59, 60].

The proteins (S) which are associated with replication, are the primary targets of post-entry treatment and these Igbo indigenous plants have viral proteinase targeting based on literature in this chapter on the anti-coronavirus properties thereby giving a hint on the inhibition of the viral replication process.

Though there is no empirical evidence in this chapter, the authors suggest that Bitter kola, Garlic, Giloy, Ginger, Lime, and Turmeric has the properties that alter the PH on the interface between the virus and the human respiratory surfaces causing a brake on the interaction with human ACE2 and where interaction has taken place, the replication and translation stages are disrupted. The plants, thus, are potential modifiers of this milieu and inhibitor of the main protease and endoribonuclease via epigenetics and homeostasis.


5. Preparations from Igbo indigenous plants towards COVID-19 eradication

The world awaits the declaration of a possible medicinal cure for COVID-19. WHO has confirmed no official treatment regimen for the COVID-19 cure [61]. The global community is searching from post to post for useful medicine in the management or treatment of COVID-19 and the related symptoms. The search could not neglect medicinal plants and herbs which has been used for the treatment of related or difficult to cure infections; the herbal remedy [62] as opined by Omer and lauds Tadepalli who tags alkaloids preparations of Indian herbal medicine as novel remedial approaches [32]. Jahan and Onay demonstrated the antiviral potentials medicinal plants that inhibit human coronaviruses [63] just as Mirzaie et al. [64] described medicinal plants as options for treatment of Coronavirus.

The preparations of the Igbo indigenous plants towards COVID-19 management and treatment may not be different from the way they are prepared for other ailments. Some studies mostly mention ginger, garlic, and lime as having antiviral properties and immune system boosting capacities [62, 63, 64, 65, 66, 67, 68, 69, 70]. Some prefer to describe them as part of nutrition that aid immunity towards the management of coronaviruses [71, 72].

There are various methods of preparations available in Igbo land towards the use of these Vitamin C enriched plants [29] in the management of COVID-19 depending on the person that is making the preparation or the status of the subject who shall be taking the preparation. There are two major methods- The water-based method (Figure 8) or the Alcohol-based method (Figure 9) and the measurement of consumption. For those who are not used to alcoholic products, the Water-based one is preferred.

Figure 8.

Water-based preparation containing ginger, turmeric, garlic, bitter kola, lime, and cinnamon.

Figure 9.

Alcohol-based preparation containing ginger, turmeric, bitter kola, lime, and garlic.

The preparations could also be made using a single plant or combination depending on the availability or the need. The preparations may be using whole plant parts or a particular part. Take, for instance, Giloy can be prepared using leaves, stem, roots at the same time, or just by using the ground dry leaves.

This chapter may not be enough to explain the ways of preparations available in Igbo land in the Eastern part of Nigeria but may convince someone of some selected indigenous plants capable of managing COVID-19. Though there is an exposition on this plant here, be it conventional or herbal medicine, self-medication is dangerous, and WHO has also not confirmed an acceptable treatment of COVID-19.


6. Conclusions

There are numerous indigenous plants in Igbo land, South Eastern Nigeria that is capable of managing coronavirus called COVID-19. Such plants include but not limited to Bitter kola (Aku ilu), Garlic (Yabasi Hausa), Giloy (Udo akpu enyi), Ginger (Jinja), Lime (Oroma nkirisi), and Turmeric (Tumerik).

The preparations for those plants differ depending on the Herbalist or the patient (subject) who needs the products, and there is always an important need to consult your Indigenous Herbal Doctor for advice and preparation.

The side effects and toxicity of plants under review in this chapter are at very high doses, especially in animal models, and mostly go away after withdrawal. It should be noted that every drug has side effects, especially when abused. These effects by natural plants and products can also be compared with synthetic and conventional drugs.

Bitter kola, Ginger, Garlic, Giloy, Turmeric, and Lime could be considered for use in the management and treatment of COVID-19 symptoms starting from Igbo land in South-Eastern Nigeria to across the globe towards ensuring that Coronavirus is eliminated before the targeted two years.

While encouraging the use of Igbo indigenous plants as a single or in a combination of at least four of them depending on the availability as they have anti-COVID-19 activities, which causes inhibition on the virus proteases within the milieu and via epigenetics and homeostasis, though there is no confirmed cure for the pandemic.



The authors wish to acknowledge all those who have used these Vitamin C enriched Igbo Indigenous plants as home remedies for all those exposed or at the risk of COVID-19 in Nigeria and other parts of the world.


Conflict of interest

The authors declare no competing interests.


Notes/Thanks/Other declarations

Obeta M. Uchejeso conceptualized the Chapter, Obeta M. Uchejeso, Ikeagwulonu R. Chinaza, Ohanube AK Goodluck and Jwanse I. Rinpan wrote the manuscript; Obeta M. Uchejeso, Ikeagwulonu R. Chinaza and Ohanube A.K Goodluck edited the chapter and approved the final manuscript for submission.


  1. 1. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19; 11 March 2020.
  2. 2. Han Y. and Yang H. (2010). The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. J Med Virol. 2020;1-6. DOI: 10.1002/jmv.25749
  3. 3. Etukudoh NS, Ejinaka RO, Olowu FA, Obeta MU, Adebowale OM, Udoudoh M P. (2020) Coronavirus (COVID-19); Review from A Nigerian Perspective. American Journal of Biomed Science & Research. - 9(1). DOI: 10.34297/AJBSR.2020.09.001347
  4. 4. Obeta MU, Ejinaka OR, Ofor IB, Ikeagwulonu R, Agbo EC, and Abara US. (2020). Nigerian COVID-19 (Coronavirus) Patients Update, the Realities with Medical Laboratory Diagnostic Sites. American Journal of Epidemiology and Infectious Disease, 8(1): 13-15. doi: 10.12691/ajeid-8-1-3.
  5. 5. Fang L. and Lanying D. (2019). MERS Coronavirus: An Emerging Zoonotic Virus. Viruses 11(7): 663.
  6. 6. Etukudoh NS, Ejinaka O, Obeta U, Utibe E, Lote-Nwaru I, Agbalaka P and Shaahia D. (2020). Zoonotic and Parasitic Agents in Bioterrorism. Journal of Infectious Diseases and Travel Medicine, 4(2):000139.
  7. 7. Bhat SA, Rather SA, Iqbal A, Qureshi HA, Islam N, Immunomodulators for Curtailing COVID-19: a Positive Approach, Journal of Drug Delivery and Therapeutics. 2020; 10(3-s):286-294
  8. 8. Tillu G, Chaturvedi S, Chopra A, Patwardhan B. (2020). Public health approach of Ayurveda and Yoga for COVID-19 prophylaxis. Journal of Alternative and Complementary Medcine.
  9. 9. Ikeagwulonu RC, Etukudoh NS, Ejinaka OR, Ibanga IE, Obeta MU, Uro-Chukwu HC and Odeh EC. (2020). Profile of Some Trace Elements in Selected Traditional Medicines used for Various Aliments in Ebonyi State, Nigeria. American Journal of Biomed Science & Research. - 9(3). DOI: 10.34297/AJBSR.2020.09.001396.
  10. 10. FMoH. (2020). First case of Coronavirus disease confirmed in Nigeria, Press Release, 27th February, 2020 Accessed on February 28, 2020. from
  11. 11. NCDC.(2020). COVID-19 Situation Report 180. Accessed from:
  12. 12. Ezekwesili-Ofili JO and Okaka ANC (2019). Herbal Medicines in African Traditional Medicine In Herbal Medicine Chapter 10, IntechOpen.
  13. 13. Lunyera JD, Wang V, Maro V. (2016): Traditional medicine practices among community members with diabetes mellitus in Northern Tanzania: An ethnomedical survey,” BMC Complementary and Alternative Medicine, 16(1), article 282,
  14. 14. Iwu MM, Igboko OA, Okunji CO. and Tempesta MS. (1990) Anti-Diabetic and Aldose Reductase Activities of Biflavanones of Garcinia kola. Journal of Pharmacology, 42, 290-292.
  15. 15. Iwu MM, Igboko OA, Onwuchekwa U. and Okunji CO. (2005) Evaluation of the Bioflavonoid of Garcinia kola Seeds. Journal of Ethno Pharmacology, 21, 127-138.
  16. 16. Mohan V, Rao GH. (2007). Type-2 Diabetes in South Asians: Epidemiology, Risk Factors and Prevention. Jaypee Medical Publishers, New Delhi, India.
  17. 17. Ukaoma AA, Ukaoma VO, Okechukwu RI, Iwuagwu M. (2013). Phytochemical screening and antibacterial properties of Garcinia kola. The Journal of Phytopharmacology. 2(3): 34-38
  18. 18. Yajnik CS. (2004). Early life origins of insulin resistance and type-2 diabetes in India and other countries. Journal of Nutrition 134: 205-210. 6.
  19. 19. Jangid H, Chaturvedi S, and Khinchi M. (2017). An overview on diabetis mellitus. Asian Journal of Pharmaceutical Research and Development; 11,
  20. 20. Piero M, Nzaro G, and Njagi J. (2015). Diabetes mellitus? a devastating metabolic disorder. Asian Journal of Biomedical and Pharmaceutical Sciences, vol. 4, no. 40, P
  21. 21. Anna Maˇnourová, Olga Leuner, Zacharie Tchoundjeu, Patrick Van Damme, Vladimír Verner, Ondˇrej Pˇriby and Bohdan Lojka (2019). Medicinal Potential, Utilization and Domestication Status of Bitter Kola (Garcinia kola Heckel) in West and Central Africa. Forests, 10, 124; doi:10.3390/f10020124
  22. 22. Badger-Emeka LI, Khalil HE, Emeka PM. Evaluation of Different Fractions of Garcinia kola Extracts against Multidrug Resistant Clinical Bacterial and Fungal Isolates. Pharmacogn J. 2018;10(5):1055-60
  23. 23. Etim, I.I., Etukudoh, N.S., Olumide, O.B., Uchejeso, M. O., Lucy, N.L. and Bwotle, F.Y. (2020) Hypoglycemic and Hypolipidemic Effect of Bitter Kola (Garcinia kola) Seed Extract on Alloxan-Induced Diabetic Albino Rats. Journal of Biosciences and Medicines, 8, 127-134.
  24. 24. Omeh YN, Onoja SO, Ezeja MI, Uchendu WC, Okorie E, and Raymond M. (2014). Quantitative Phytochemical, Proximate Analysis and Hypolipidemic Effect of Garcinia kola. British Journal of Medicine & Medical Research 4(36): 5770-5778
  25. 25. Abarikwu SO. Kolaviron, a natural flavonoid from the seeds of Garcinia kola, reduces LPS-induced inflammation in macrophages by combined inhibition of IL-6 secretion, and inflammatory transcription factors, ERK1/2, NF-κB, p38, Akt, p-c-JUN and JNK. Biochim Biophys Acta. 2014;1840(7):2373-2381. doi:10.1016/j.bbagen.2014.03.006
  26. 26. Nworu SC, Akah P, Esimone CO, Okoli CO, Okoye F. (2008). Immunomodulatory Activities of Kolaviron, a Mixture of Three Related Biflavonoids of Garcinia kola Heckel Immunopharmacology and Immunotoxicology 30(2):317-32 DOI: 10.1080/08923970801925430
  27. 27. Bahare S, Nanjangud V, Anil K, Bilge ¸S, Mehdi SR, Mehtap K, Gail BM, Sanja V, Marcello I, Farzad K, William NS, Seyed AA, Athar A, Javad SR.(2018) Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus. International Journal of Molecular Science; 19, 1459; doi:10.3390/ijms19051459
  28. 28. Gustafson KR, Blunt JW, Munro MHG, Fuller RW, McKee TC, Cardellina JH, McMahon JB, Cragg GM, Boyd MR. (1992). The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea” Tetrahedron. 1992, 48, 10093-10102
  29. 29. Vezele Y. (2015). Garcinia kola: Phytochemical, Biological and Formulation Studies. Master’s Thesis in University of Rhode Island.
  30. 30. Ohanube GAK, Obeta MU, Ikeagwulonu RC, and Jwanse IR, (2020). COVID-19: A Case Study of Using Vitamin C Enriched Plants and Ascorbic Acid as Cure. American Journal of Medical Case Reports, 8(11): 435-437. doi: 10.12691/ajmcr-8-11-16.
  31. 31. Ameh, GI, Eze SC and Omeje FU (2013). Phytochemical screening and antimicrobial studies on the methanolic bulb extract of Allium sativum L. African Journal of Biotechnology. 12(14), 1665-1668 DOI: 10.5897/AJB12.842. Available online at
  32. 32. Singh D and Kumar VS. (2008). Pharmacological Effects of Garlic (Allium sativum L.) Annual Review of Biomedical Sciences 10. DOI: 10.5016/1806-8774.2008.v10p6
  33. 33. Tadepalli SP. (2020). Novel Remedial Approaches Against Virulent Corona Viruses. International Journal of Infectious Diseases and Research 1(1): 1-15
  34. 34. Weber ND, Anderson DO, North JA, Murray BK, Lawson LD, Hughes BG. (1992). In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Medicine. 1992; 58(5):417-423. doi:10.1055/s-2006-961504
  35. 35. Kang JS, Kim SO, Kim GY, Hwang HJ, Kim BW, Chang YC, Kim WJ, Kim CM, Yoo YH, Choi YH. (2026). An exploration of the antioxidant effects of garlic saponins in mouse-derived C2C12 myoblasts. International Journal of Molecular Medicine; 37:149-156. doi: 10.3892/ijmm.2015.2398.
  36. 36. Naji KM, Al-Shaibani ES, Alhadi FA, Al-Soudi SA, D’Souza MR. (2017). Hepatoprotective and antioxidant effects of single clove garlic against ccl4-induced hepatic damage in rabbits. BMC Complement. Alternative Medicine; 17:411. doi: 10.1186/s12906-017-1916-8.
  37. 37. Nwokocha CR, Ozolua RI, Owu DU, Nwokocha MN, Ufearo CS, Iwuala MOE. (2011). Antihypertensive properties of Allium sativum on normotensive and two kidney one clip hypertensive rats. Nigerian Journal of Physiological Science.;26(2):213-218
  38. 38. Fowotade AA, Fowotade A, Enaibe BU and Avwioro GO (2017). Evaluating Toxicity Profile of Garlic (Allium sativum) on the Liver, Kidney and Heart Using Wistar Rat Model. International Journal of Tropical Disease & Health 26(2): 1-12. DOI: 10.9734/IJTDH/2017/36282
  39. 39. Singh D and Chaudhuri PK. (2017) Chemistry and Pharmacology of Tinospora cordifolia. Natural Product Communications 12(2) 299-308
  40. 40. Singh S, Maan NS, Rana V, Jyotsana J, Tewatia BS, Sheoran N (2018). Effect of dietary inclusion of Giloy (Tinospora cordifolia) stem powder on growth performance and metabolizability in broilers. Journal of Entomology and Zoology Studies 2018; 6(5): 36-40
  41. 41. Mainzen PS, Menon VP.(2003). Hypoglycaemic and hypolipidaemic action of alcohol extract of Tinospora cordifolia roots in chemical induced diabetes in rats. Phytotherapy Research;17:410-413.
  42. 42. Vedavathy S, Rao KN. Antipyretic activity of six indigenous medicinal plants of Tirumala Hilla, Andhra Pradesh. (1991). Indian Journal of Ethnopharmacology; 33:193-196.
  43. 43. Gupta PC, Pant D, Joshi Lohar DR. (2010). Evaluation of antibacterial activity of Lepidium sativum against food borne pathogens. International Journal of Chemical and analytical sciences, 1, 74-75
  44. 44. Vwioko DE, Osemwegie OO, and Akawe JN. (2013). The effect of garlic and ginger phytogenics on the shelf life and microbial contents of homemade soursop (Annona muricata L) fruit juice Biokemistri. International Journal of the Nigerian Society for Experimental Biology 25 (2) 31-38
  45. 45. Adeniyi PO. (2019). Bitter Foods are Sometimes Better. World Journal of Preventive Medicine, vol. 7, no. 1: 1-8. DOI: 10.12691/jpm-7-1-1.
  46. 46. Iman A. E. and Ibrahim A. A. (2009). A Study of the Cardiovascular Toxic Effects of Zingiber officinale (Ginger) in Adult Male Albino Rats and its Possible Mechanisms of Action. Mansoura Journal of Forensic Medicine and Clinical Toxicology. 27 (2), 109-128
  47. 47. Idang, EO, Yemitan OK, Mbagwu HOC ,. Udom GJ, Ogbuagu EO and Udobang JA. (2019). Toxicological Assessment of Zingiber officinale Roscoe (Ginger) Root Oil Extracts in Albino rats. Toxicology Digest 4 (1): 108-119
  48. 48. Rana S, and Dixit S (2017) Screening of Phytochemicals in Citrus limonum Peel Extract to Evaluate Its Antimicrobial Potential. International Journal of Natural Products Research 2017; 7(2): 7-16
  49. 49. Mathew BB, Jatawa SK, Tiwari A. (2011). Phytochemical Analysis Of Citrus limonum Pulp and Peel Int J Pharm Pharm Sci, 4(2), 269-371
  50. 50. Ehigbai I. Oikeh EI, Omoregie ES, Oviasogie FE, Oriakhi K. (2015). Phytochemical, antimicrobial, and antioxidant activities of different citrus juice concentrates. Food Science & Nutrition. Doi: 10.1002/fsn3.268
  51. 51. Gupta S, Gupta C, Prakash D, and Garg AP. (2017) Comparative Study of Antimicrobial Effects of Lemon Oil and Page 3 of 5Peel Extract against Food-Spoilage Microbes. J Nutrition Health Food Sci 5(6):1-5. DOI:
  52. 52. Kumar KJS., Vani MG, Wang CS, Chen CC, Chen YC, Lu LP, Huang CH, Lai CS and Wang SY. (2020) Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells. Plants 2020, 9, 770; doi:10.3390/plants9060770
  53. 53. Soheil ZM, Habsah AK, Pouya H, Hassan T, Sazaly A, and Keivan Z. (2014). A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin. BioMed Research International 2014(1), 1-12
  54. 54. Mbadiko CM, Inkoto CL, Benjamin Z. Gbolo BZ, Lengbiye EM, Kilembe JT, Matondo A, Mwanangombo DT, Ngoyi EM, Bongo GN, Falanga CM, Tshibangu DST, Tshilanda DD, Ngbolua KN, and Mpiana PT. (2020). A Mini Review on the Phytochemistry, Toxicology and Antiviral Activity of Some Medically Interesting Zingiberaceae Species. Journal of Complementary and Alternative Medical Research 9(4): 44-56, DOI: 10.9734/JOCAMR/2020/v9i430150
  55. 55. Aggarwal ML, Chacko KM and Kuruvilla BT. (2016) Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation. Molecular Medicine Reports 13: 592-604. DOI: 10.3892/mmr.2015.4579
  56. 56. Balaji S, and Chempakam B. (2010). Toxicity prediction of compounds from turmeric (Curcuma longa L). Food and Chemical Toxicology 48: 2951-2959.
  57. 57. Estefanı’a BM, Jose´ MCM, Javier S, Antonio R and Miguel LL. (2010). The dark side of curcumin. International Journal of Cancer 126, 1771-1775
  58. 58. Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health: TM & IH, 25(3), 278-280.
  59. 59. Chowdhury P. (2020). In Silico Investigation of Phytoconstituents from Indian Medicinal Herb ‘Tinospora cordifolia (Giloy)’ against SARS-CoV-2 (COVID-19) by Molecular Dynamics Approach. Journal of Biomolecular Structure and Dynamics.
  60. 60. Sharma A, Goyal S, Yadav AK, Kumar P, Gupta L. (2020). In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics.
  61. 61. Ikeagwulonu RC, Etukudoh NS, Obeta MU, Mgbecheta CU. (2020). Does Vitamin D Serum Levels Affect The Risk of Covid 19 and its Clinical Outcomes? A Review of Literature. East African Scholars J Med Surg; 2(6): 146-151
  62. 62. Omer AA. (2020). Against COVID-19: Herbal Theory. Saudi Journal of Biomedical Research. 5(5): 80-81. DOI: 10.36348/sjbr.2020.v05i05.002
  63. 63. Jahan I. and Onay A. (2020). Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turkey Journal of Biology. 44: 228-241 doi:10.3906/biy-2005-114
  64. 64. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. (2020). A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complementary Therapies in Clinical Practice. (40):101214
  65. 65. Mehrbod P, Amini E, Tavassoti-Kheiri M. (2009). Antiviral activity of garlic extract on Influenza virus. Iranian Journal of Virology 2008/ 2009; 2 (1).
  66. 66. Chaturvedi S, Kumar N, Tillu G, Deshpande S, Patwardhan B. (2020). AYUSH, modern medicine and the Covid-19 pandemic. Indian Journal of Medical Ethics. DOI: 10.20529/IJME.2020.058
  67. 67. Abdul MI, Siddique MS, Rahman SAU. (2018). A critical insight of modern herbal drugs therapy under the purview of toxicity and authenticity, Biomedical Research (India), 29(16): 3255-3260,
  68. 68. Nandedkar MA, Mahajan SV, Pardeshi KM, Oswal RJ and Shah MS (2010). Novel Perception on the Anti - Viral Effect of Bioactive Natural Molecules Against COVID −19. World Journal of Pharmaceutical Research 9(7), 674-696. DOI: 10.20959/wjpr20207-17843
  69. 69. Kumar A, Kumar R, Sharma M, Kumar U, Gajula MNVP, Singh KP. (2018). Uttarakhand medicinal plants database (UMPDB): a platform for exploring genomic, chemical, and traditional knowledge. Data (MDPI), 3(1), 7. DOI: 10.3390/data3010007.
  70. 70. Akram M, Tahir IM, Shah SMA, Mahmood Z, Altaf A et al. (2018). Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: a systematic review. Phytotherapy Research 32 (5): 811-822. doi:10.1002/ptr.6024
  71. 71. Khaled MB. and Benajiba N. (2020). The role of nutrition in strengthening immune system against newly emerging viral diseases: case of SARS-CoV-2. The North African Journal of Food and Nutrition Research. 4(7): 240-44
  72. 72. Ren J, Jin X, Gao Y, Li R, Li J, Zhang J, Wang X, and Wang G. (2020). Vitamin C: a misunderstood ally? Critical Care 24(8)

Written By

Obeta M. Uchejeso, Ikeagwulonu R. Chinaza, Ohanube A.K. Goodluck and Jwanse I. Rinpan

Submitted: 18 August 2020 Reviewed: 29 September 2020 Published: 09 November 2020